These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2650105)

  • 1. Differential effects of immunosuppressive agents on mononuclear cells infiltrating human renal allografts.
    Cunningham PR; Gross U; Matthews C; Sash C; Thomas F; Thomas J
    Transplant Proc; 1989 Feb; 21(1 Pt 1):194-5. PubMed ID: 2650105
    [No Abstract]   [Full Text] [Related]  

  • 2. Subpopulations of peripheral blood mononuclear cells are reliable for monitoring infiltrating mononuclear cells.
    Takahara S; Sakakibara I; Suzuki S; Amemiya H; Kokado Y; Ishibashi M; Sonoda T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1846-51. PubMed ID: 2652601
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunopharmacologic effects of immunosuppressive agents explored by a new effector monocyte generation assay.
    Ishibashi M; Jiang S; Kokado Y; Takahara S; Sonoda T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1854-8. PubMed ID: 2469228
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnosis of renal allograft rejection by analysis of infiltrating cell profiles: an assessment of cyclosporine, azathioprine/prednisolone, and triple therapy.
    McWhinnie DL; Azevedo LS; Carter NP; Cranston D; Jones R; Wood RF; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1633-4. PubMed ID: 3152633
    [No Abstract]   [Full Text] [Related]  

  • 5. Some experimental and clinical studies of Cyclosporin A in renal transplantation.
    Morris PJ
    Transplant Proc; 1982 Sep; 14(3):525-8. PubMed ID: 6758238
    [No Abstract]   [Full Text] [Related]  

  • 6. Histologic findings in acute renal allograft rejection with triple drug immunosuppressive therapy: a retrospective analysis.
    Moreno RF; Pallardo LM; Garcia J; Sanchez J; Rochera A; Cabezuelo J; de Agustin PP
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):5-6. PubMed ID: 3051590
    [No Abstract]   [Full Text] [Related]  

  • 7. Conversion from azathioprine and/or prednisolone to cyclosporine A in renal allograft recipients.
    Ebel H; Lange H
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2005-6. PubMed ID: 3274463
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppression with cyclosporine, azathioprine, and prednisolone in cadaver renal allograft recipients.
    Jones RM; Murie JA; Allen R; Jaskowski A; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1926. PubMed ID: 3274453
    [No Abstract]   [Full Text] [Related]  

  • 9. Monitoring of renal allografts under immunosuppression.
    Hammer C
    Z Exp Chir Transplant Kunstliche Organe; 1986; 19(6):340-2. PubMed ID: 3548110
    [No Abstract]   [Full Text] [Related]  

  • 10. Transfer of cytomegalovirus infection via renal allografts: role of immunosuppressive regimens on the transfer rate, and effect of cytomegalovirus infections on renal allograft rejection; study in a rat model.
    Bruning JH; Bruggeman CA; van Breda Vriesman PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2089-90. PubMed ID: 2540562
    [No Abstract]   [Full Text] [Related]  

  • 11. Control of rejection of transplanted organs.
    Keown PA; Stiller CR
    Adv Intern Med; 1986; 31():17-46. PubMed ID: 3511616
    [No Abstract]   [Full Text] [Related]  

  • 12. Nocardia infection in a renal transplant unit.
    Leaker B; Hellyar A; Neild GH; Rudge C; Mansell M; Thompson FD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2103-4. PubMed ID: 2652677
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of three immunosuppressive regimens in high-risk patients: immunologic aspects.
    Renna Molajoni E; Bachetoni A; Cinti P; Sallustio F; Rossi M; Pretagostini R; Orlandini A; Berloco P; Alfani D; Cortesini R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1978-80. PubMed ID: 3079064
    [No Abstract]   [Full Text] [Related]  

  • 14. Phenotypic analysis of mononuclear cells infiltrating rat renal allografts during ongoing rejection.
    Hamashima T; Yoshimura N; Oka T
    Transplant Proc; 1989 Feb; 21(1 Pt 1):356-7. PubMed ID: 2650149
    [No Abstract]   [Full Text] [Related]  

  • 15. Adrenal function as an index of the immunosuppressive activity of glucocorticoids (prednisolone) in renal allograft recipients.
    Kozaki M; Hirano T; Oka K
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2237-9. PubMed ID: 3079076
    [No Abstract]   [Full Text] [Related]  

  • 16. Contribution of T-cell subset monitoring of renal transplant recipients in the cyclosporine era.
    Khanuja PS; Toledo-Pereyra LH; Gordon DA; Bandlien KO; Whitten JI
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1852-3. PubMed ID: 2652602
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of triple therapy with double therapy (cyclosporine/azathioprine) in low-risk, first cadaveric renal allograft recipients.
    Restifo AC; Petrie JJ; Rigby RJ; Hardie IR; Jacob CK; Russ GR; Mathew TH
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1604-5. PubMed ID: 2652522
    [No Abstract]   [Full Text] [Related]  

  • 18. Late onset acute rejection of renal allografts, an indicator of suboptimum cyclosporin dosage.
    Sumethkul V; Jirasiritham S; Chiewsilp P
    Transplant Proc; 1996 Jun; 28(3):1461-2. PubMed ID: 8658741
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of mononuclear cell populations infiltrating human renal allografts.
    Waltzer WC; Miller F; Arnold A; Anaise D; Rapaport FT
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1629-32. PubMed ID: 3547872
    [No Abstract]   [Full Text] [Related]  

  • 20. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
    Reissi D; Bardideh A; Samadzadeh B; Razi A
    Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.